Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
FTSE 100 movers: JD Sports rallies; GSK hit by US Zantac ruling
(Sharecast News) - London's FTSE 100 was flat at 8,276.38 in afternoon trade on Monday. JD Sports jumped to the top of the index, having slumped on Friday after full-year results.
St James's Place rallied after an upgrade to 'overweight' from 'neutral' at JPMorgan Cazenove, which cited an attractive valuation and reducing uncertainty.
"Whilst we believe that negative news is largely behind us, this has not been reflected in valuation, with St James's Place trading at 7x FY25e," it said. "We expect that sentiment will improve given the resilience in gross flows, and we see upside to consensus net flow estimates."
Mike Ashley's Frasers Group was also in the black as it announced the appointment of Sir Jon Thompson, former chief executive officer of the Financial Reporting Council, as a non-executive director.
Thomson has also been chair of HS2, CEO of HMRC, and permanent secretary of the Ministry of Defence, where he oversaw major projects.
GSK tumbled after a US court ruled that jury trials could hear expert witnesses in cases brought by cancer sufferers claiming its Zantac heartburn drug caused their condition.
A judge in the Delaware State Court ruled that scientific experts would be able to testify there is a link between the plaintiffs' illnesses and their exposure to probable human carcinogens, through the Zantac drug.
FTSE 100 - Risers
JD Sports Fashion (JD.) 136.65p 7.18% St James's Place (STJ) 521.00p 4.28% Entain (ENT) 700.80p 3.79% easyJet (EZJ) 474.80p 3.22% Ocado Group (OCDO) 384.80p 3.00% Rightmove (RMV) 547.40p 2.66% International Consolidated Airlines Group SA (CDI) (IAG) 175.25p 2.25% CRH (CDI) (CRH) 6,248.00p 2.12% Frasers Group (FRAS) 900.00p 2.10% Land Securities Group (LAND) 665.00p 1.92%
FTSE 100 - Fallers
GSK (GSK) 1,612.00p -8.75% BP (BP.) 482.00p -1.26% Anglo American (AAL) 2,488.00p -1.01% Severn Trent (SVT) 2,365.00p -0.88% Compass Group (CPG) 2,174.00p -0.82% Fresnillo (FRES) 614.50p -0.81% Ashtead Group (AHT) 5,646.00p -0.74% Rio Tinto (RIO) 5,439.00p -0.68% United Utilities Group (UU.) 1,009.50p -0.64% Pearson (PSON) 942.60p -0.57%
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Doing Business with Fidelity | Diversity, Equity & Inclusion Reports | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.
